Organization Overview
Historical Acquisition Tree
Alternative names
albumin (Human) (Plasbumin) (1997)
calcium (1974)
calcium-47 (1968 NDA)
cyanocobalamin (berocca) (1974)
cyanocobalamin co-57 (rubratope-57) (1974)
cyanocobalamin co-58 (1974)
diatrazoate meglumine (Renografin) (1954)
etidronic acid (1976)
flutemetamol F-18 (vizamyl) (2013 NDA)
gadodiamide (omniscan) (1993 NDA)
gadoteric acid (Dotarem) (2019)
gallium citrate ga 67 (1977)
indium in-111 (1992)
indium in-111 pentetate (1982)
iobenguane (123i) (2008 NDA)
iodixanol (visipaque) (1996 NDA)
iodohippurate sodium i-123 (nephroflow) (1984 NDA)
ioflupane i-123 (2011 NDA)
iohexol (Omnipaque) (1985)
iopanoic acid (telepaque) (1951 NDA)
meglumine (1974)
metrizamide (amipaque) (1978 NDA)
metrizoic acid (1973)
mpi krypton 81m generator (1980)
oxine (1985)
selenomethionine se-75 (1976)
sodium fluoride-18f (1972)
sodium iodide i-123 (1976)
succimer (chemet) (1982)
tc-99m albumin (1976)
technetium-99m exametazine (1988)
technetium tc-99m medronate kit (1979)
technetium tc-99m pentetate kit (renotec) (1974)
technetium tc-99m polyphosphate kit (sodium polyphosphate-tin kit) (1982 NDA)
technetium tc-99m sulfur colloid kit (Tesuloid) (1976)
technetium tc-99m tetrofosmin kit (1996)
thallous chloride ti 201 (1982)
tyropanoate sodium (bilopaque) (1969 NDA)
ultra-technekow fm (1974)
xenon xe-133 (1976)
acetylcysteine (mucomyst) (1 trial)
diatrazoate meglumine (Renografin) (2 trials)
evolocumab (repatha) (1 trial)
gadobenate (multihance) (1 trial)
gadoteric acid (Dotarem) (1 trial)
gadoteridol (prohance) (1 trial)
gadoxetate disodium (eovist) (1 trial)
Key: General Electric (11) Acquired (1)
Key: General Electric (16) Acquired (2)
Alzheimer Disease (Phase 3)
Amyloidosis (Phase 3)
Arterial Occlusive Diseases (Phase 3)
Atrophy (Phase 3)
Body Weight (Phase 4)
Breast Neoplasms (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiomyopathies (Phase 4)
Carotid Artery Diseases (Phase 2)
Chronic Pain (Phase 1)
Cognitive Dysfunction (Phase 3)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Dementia (Phase 3)
Dementia, Vascular (Phase 3)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Embolism (Phase 4)
Fatty Liver (Phase 2)
Fever (Phase 1)
Glioma (Phase 1)
Head and Neck Neoplasms (Phase 2)
Heart Diseases (Phase 2)
Heart Failure (Phase 3)
Hydrocephalus (Phase 3)
Hydrocephalus, Normal Pressure (Phase 3)
Hypertension, Pulmonary (Phase 4)
Hypothyroidism (Phase 4)
Infarction (Phase 4)
Ischemia (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Leukemia, Promyelocytic, Acute (Phase 1)
Lewy Body Disease (Phase 3)
Liver Diseases (Phase 2)
Lung Neoplasms (Phase 4)
Melanoma (Phase 2)
Multiple Sclerosis (Phase 1)
Multiple Sclerosis, Relapsing-Remitting (Phase 1)
Multiple System Atrophy (Phase 3)
Myocardial Ischemia (Phase 4)
Neuralgia (Phase 1)
Neuroblastoma (Phase 3)
Nociceptive Pain (Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 2)
Parkinson Disease (Phase 3)
Pheochromocytoma (Phase 3)
Prostatic Neoplasms (Phase 2)
Pulmonary Embolism (Phase 4)
Recurrence (Phase 4)
Renal Artery Obstruction (Phase 4)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Sarcoma (Phase 2)
Sclerosis (Phase 1)
Shy-Drager Syndrome (Phase 3)
Supranuclear Palsy, Progressive (Phase 3)
Syndrome (Phase 3)
Triple Negative Breast Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 4)
Uterine Neoplasms (Phase 2)
Ventricular Dysfunction (Phase 4)
Ventricular Dysfunction, Left (Phase 4)
Yellow Fever (Phase 1)